Related references
Note: Only part of the references are listed.A 3D Alzheimer's disease culture model and the induction of P21-activated kinase mediated sensing in iPSC derived neurons
Dawei Zhang et al.
BIOMATERIALS (2014)
GWAS and drug targets
Chen Cao et al.
BMC GENOMICS (2014)
The multi-functional drug tropisetron binds APP and normalizes cognition in a murine Alzheimer's model
Patricia Spilman et al.
BRAIN RESEARCH (2014)
Dimethyl Fumarate: A Review of Its Use in Patients with Relapsing-Remitting Multiple Sclerosis
Celeste B. Burness et al.
CNS DRUGS (2014)
Valproic Acid Reduces Neuritic Plaque Formation and Improves Learning Deficits in APPSwe/PS1A246E Transgenic Mice via Preventing the Prenatal Hypoxia-Induced Down-Regulation of Neprilysin
Zheng Wang et al.
CNS NEUROSCIENCE & THERAPEUTICS (2014)
Toward better drug repositioning: prioritizing and integrating existing methods into efficient pipelines
Guangxu Jin et al.
DRUG DISCOVERY TODAY (2014)
Prion-like Properties of Tau Protein: The Importance of Extracellular Tau as a Therapeutic Target
Brandon B. Holmes et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
A three-dimensional human neural cell culture model of Alzheimer's disease
Se Hoon Choi et al.
NATURE (2014)
Clinical development success rates for investigational drugs
Michael Hay et al.
NATURE BIOTECHNOLOGY (2014)
R&D productivity: on the comeback trail
Ulrik Schulze et al.
NATURE REVIEWS DRUG DISCOVERY (2014)
Efficient derivation of cortical glutamatergic neurons from human pluripotent stem cells: A model system to study neurotoxicity in Alzheimer's disease
Tandis Vazin et al.
NEUROBIOLOGY OF DISEASE (2014)
Liraglutide can reverse memory impairment, synaptic loss and reduce plaque load in aged APP/PS1 mice, a model of Alzheimer's disease
Paula L. McClean et al.
NEUROPHARMACOLOGY (2014)
Clioquinol promotes the degradation of metal-dependent amyloid-β (Aβ) oligomers to restore endocytosis and ameliorate Aβ toxicity
Kent E. S. Matlack et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Parallel Discovery of Alzheimer's Therapeutics
Andrew W. Lo et al.
SCIENCE TRANSLATIONAL MEDICINE (2014)
Use Patents Can Be Useful: The Case of Rescued Drugs
Arti K. Rai et al.
SCIENCE TRANSLATIONAL MEDICINE (2014)
An Antidepressant Decreases CSF Aβ Production in Healthy Individuals and in Transgenic AD Mice
Yvette I. Sheline et al.
SCIENCE TRANSLATIONAL MEDICINE (2014)
Fyn kinase inhibition as a novel therapy for Alzheimer's disease
Haakon B. Nygaard et al.
ALZHEIMERS RESEARCH & THERAPY (2014)
Alzheimer's disease drug-development pipeline: few candidates, frequent failures
Jeffrey L. Cummings et al.
ALZHEIMERS RESEARCH & THERAPY (2014)
Midlife Hypertension and 20-Year Cognitive Change The Atherosclerosis Risk in Communities Neurocognitive Study
Rebecca F. Gottesman et al.
JAMA NEUROLOGY (2014)
Repackaging FDA-approved drugs for degenerative diseases: promises and challenges
Jeffrey L. Cummings et al.
EXPERT REVIEW OF CLINICAL PHARMACOLOGY (2014)
Overcoming obstacles to repurposing for neurodegenerative disease
Diana W. Shineman et al.
ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2014)
Phenotypic Screens Targeting Neurodegenerative Diseases
Minhua Zhang et al.
JOURNAL OF BIOMOLECULAR SCREENING (2014)
Phosphodiesterase-5 inhibitor sildenafil prevents neuroinflammation, lowers beta-amyloid levels and improves cognitive performance in APP/PS1 transgenic mice
Junfang Zhang et al.
BEHAVIOURAL BRAIN RESEARCH (2013)
Modeling Alzheimer's Disease with iPSCs Reveals Stress Phenotypes Associated with Intracellular Aβ and Differential Drug Responsiveness
Takayuki Kondo et al.
CELL STEM CELL (2013)
Phenotypic Assays for β-Amyloid in Mouse Embryonic Stem Cell-Derived Neurons
Laura Beth J. McIntire et al.
CHEMISTRY & BIOLOGY (2013)
Computational Drug Repositioning: From Data to Therapeutics
M. R. Hurle et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2013)
Network-Based Approaches in Drug Discovery and Early Development
J. M. Harrold et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2013)
Antiepileptics Topiramate and Levetiracetam Alleviate Behavioral Deficits and Reduce Neuropathology in APPswe/PS1dE9 Transgenic Mice
Jian-Quan Shi et al.
CNS NEUROSCIENCE & THERAPEUTICS (2013)
Valproic Acid Attenuates Neuronal Loss in the Brain of APP/PS1 Double Transgenic Alzheimer's Disease Mice Model
Zhimin Long et al.
CURRENT ALZHEIMER RESEARCH (2013)
A High-Throughput Screening Assay for Determining Cellular Levels of Total Tau Protein
Seameen J. Dehdashti et al.
CURRENT ALZHEIMER RESEARCH (2013)
Discovering New Treatments for Alzheimer's Disease by Repurposing Approved Medications
Brian S. Appleby et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2013)
Tadalafil crosses the blood-brain barrier and reverses cognitive dysfunction in a mouse model of AD
Carolina Garcia-Barroso et al.
NEUROPHARMACOLOGY (2013)
MOLECULAR LINKS BETWEEN ALZHEIMER'S DISEASE AND DIABETES MELLITUS
Y. Yang et al.
NEUROSCIENCE (2013)
Unintended Effects of Cardiovascular Drugs on the Pathogenesis of Alzheimer's Disease
Jun Wang et al.
PLOS ONE (2013)
Prevention of β-amyloid induced toxicity in human iPS cell-derived neurons by inhibition of Cyclin-dependent kinases and associated cell cycle events
Xiaohong Xu et al.
STEM CELL RESEARCH (2013)
A safe lithium mimetic for bipolar disorder
Nisha Singh et al.
NATURE COMMUNICATIONS (2013)
Mechanisms of Protein Seeding in Neurodegenerative Diseases
Lary C. Walker et al.
JAMA NEUROLOGY (2013)
Seizures and Epileptiform Activity in the Early Stages of Alzheimer Disease
Keith A. Vossel et al.
JAMA NEUROLOGY (2013)
FRET-Based Calcium Imaging: A Tool for High-Throughput/Content Phenotypic Drug Screening in Alzheimer Disease
Kamran Honarnejad et al.
JOURNAL OF BIOMOLECULAR SCREENING (2013)
Phosphodiesterases as Therapeutic Targets for Alzheimer's Disease
Ana Garcia-Osta et al.
ACS CHEMICAL NEUROSCIENCE (2012)
Presenilin-1 L166P Mutant Human Pluripotent Stem Cell Derived Neurons Exhibit Partial Loss of γ-Secretase Activity in Endogenous Amyloid-β Generation
Philipp Koch et al.
AMERICAN JOURNAL OF PATHOLOGY (2012)
Intranasal Insulin Therapy for Alzheimer Disease and Amnestic Mild Cognitive Impairment A Pilot Clinical Trial
Suzanne Craft et al.
ARCHIVES OF NEUROLOGY (2012)
A searchable cross-platform gene expression database reveals connections between drug treatments and disease
Gareth Williams
BMC GENOMICS (2012)
Drugs developed to treat diabetes, liraglutide and lixisenatide, cross the blood brain barrier and enhance neurogenesis
Kerry Hunter et al.
BMC NEUROSCIENCE (2012)
Inhibitory Interneuron Deficit Links Altered Network Activity and Cognitive Dysfunction in Alzheimer Model
Laure Verret et al.
CELL (2012)
APP physiological and pathophysiological functions: insights from animal models
Qinxi Guo et al.
CELL RESEARCH (2012)
Modeling Brain Disease in a Dish: Really?
Maria C. Marchetto et al.
CELL STEM CELL (2012)
Phenotypic Screening Strategies for Neurodegenerative Diseases: A Pathway to Discover Novel Drug Candidates and Potential Disease Targets or Mechanisms
R. M. Pruss
CNS & Neurological Disorders-Drug Targets (2012)
Alzheimers disease in a dish: promises and challenges of human stem cell models
Jessica E. Young et al.
HUMAN MOLECULAR GENETICS (2012)
Small Molecule Structure Correctors Abolish Detrimental Effects of Apolipoprotein E4 in Cultured Neurons
Hung-Kai Chen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
A Novel Inhibitor of Amyloid β (Aβ) Peptide Aggregation FROM HIGH THROUGHPUT SCREENING TO EFFICACY IN AN ANIMAL MODEL OF ALZHEIMER DISEASE
Angela Fortner McKoy et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Modern Phenotypic Drug Discovery Is a Viable, Neoclassic Pharma Strategy
Jonathan A. Lee et al.
JOURNAL OF MEDICINAL CHEMISTRY (2012)
The Complex PrPc-Fyn Couples Human Oligomeric Aβ with Pathological Tau Changes in Alzheimer's Disease
Megan Larson et al.
JOURNAL OF NEUROSCIENCE (2012)
Utility of an improved model of amyloid-beta (Aβ1-42) toxicity in Caenorhabditis elegans for drug screening for Alzheimer's disease
Gawain McColl et al.
MOLECULAR NEURODEGENERATION (2012)
NCATS launches drug repurposing program
Malorye Allison
NATURE BIOTECHNOLOGY (2012)
Use of genome-wide association studies for drug repositioning
Philippe Sanseau et al.
NATURE BIOTECHNOLOGY (2012)
Alzheimer amyloid-β oligomer bound to postsynaptic prion protein activates Fyn to impair neurons
Ji Won Um et al.
NATURE NEUROSCIENCE (2012)
Drug repurposing programmes get lift off
Asher Mullard
NATURE REVIEWS DRUG DISCOVERY (2012)
Drug repositioning for Alzheimer's disease
Anne Corbett et al.
NATURE REVIEWS DRUG DISCOVERY (2012)
Diagnosing the decline in pharmaceutical R&D efficiency
Jack W. Scannell et al.
NATURE REVIEWS DRUG DISCOVERY (2012)
Stem cells assessed
Cedric Blanpain et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2012)
Val(8)GLP-1 rescues synaptic plasticity and reduces dense core plaques in APP/PS1 mice
Simon Gengler et al.
NEUROBIOLOGY OF AGING (2012)
Mechanisms Underlying Insulin Deficiency-Induced Acceleration of β-Amyloidosis in a Mouse Model of Alzheimer's Disease
Latha Devi et al.
PLOS ONE (2012)
Metformin attenuates Alzheimer's disease-like neuropathology in obese, leptin-resistant mice
Jiejie Li et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2012)
Levetiracetam suppresses neuronal network dysfunction and reverses synaptic and cognitive deficits in an Alzheimer's disease model
Pascal E. Sanchez et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Chronic Divalproex Sodium to Attenuate Agitation and Clinical Progression of Alzheimer Disease
Pierre N. Tariot et al.
ARCHIVES OF GENERAL PSYCHIATRY (2011)
Sildenafil restores cognitive function without affecting β-amyloid burden in a mouse model of Alzheimer's disease
M. Cuadrado-Tejedor et al.
BRITISH JOURNAL OF PHARMACOLOGY (2011)
Impact of induced pluripotent stem cells on the study of central nervous system disease
Paige E. Cundiff et al.
CURRENT OPINION IN GENETICS & DEVELOPMENT (2011)
Selective dihydropyiridine compounds facilitate the clearance of β-amyloid across the blood-brain barrier
Corbin Bachmeier et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2011)
Perindopril, a centrally active angiotensin-converting enzyme inhibitor, prevents cognitive impairment in mouse models of Alzheimer's disease
Yi-Fei Dong et al.
FASEB JOURNAL (2011)
Modeling familial Alzheimer's disease with induced pluripotent stem cells
Takuya Yagi et al.
HUMAN MOLECULAR GENETICS (2011)
Amyloid-β/Fyn-Induced Synaptic, Network, and Cognitive Impairments Depend on Tau Levels in Multiple Mouse Models of Alzheimer's Disease
Erik D. Roberson et al.
JOURNAL OF NEUROSCIENCE (2011)
The Diabetes Drug Liraglutide Prevents Degenerative Processes in a Mouse Model of Alzheimer's Disease
Paula L. McClean et al.
JOURNAL OF NEUROSCIENCE (2011)
Renin-angiotensin system blockade and cognitive function in patients at high risk of cardiovascular disease: analysis of data from the ONTARGET and TRANSCEND studies
Craig Anderson et al.
LANCET NEUROLOGY (2011)
Selective Antihypertensive Dihydropyridines Lower Aβ Accumulation by Targeting both the Production and the Clearance of Aβ across the Blood-Brain Barrier
Daniel Paris et al.
MOLECULAR MEDICINE (2011)
How were new medicines discovered?
David C. Swinney et al.
NATURE REVIEWS DRUG DISCOVERY (2011)
The productivity crisis in pharmaceutical R&D
Fabio Pammolli et al.
NATURE REVIEWS DRUG DISCOVERY (2011)
Carvedilol as a potential novel agent for the treatment of Alzheimer's disease
Jun Wang et al.
NEUROBIOLOGY OF AGING (2011)
L-type voltage-gated calcium channel blockade with isradipine as a therapeutic strategy for Alzheimer's disease
Thimmappa S. Anekonda et al.
NEUROBIOLOGY OF DISEASE (2011)
Constructing and Deconstructing Stem Cell Models of Neurological Disease
Steve S. W. Han et al.
NEURON (2011)
5-HT4 receptor agonist mediated enhancement of cognitive function in vivo and amyloid precursor protein processing in vitro: A pharmacodynamic and pharmacokinetic assessment
Fei Shen et al.
NEUROPHARMACOLOGY (2011)
Peripheral insulin-sensitizer drug metformin ameliorates neuronal insulin resistance and Alzheimer's-like changes
Amit Gupta et al.
NEUROPHARMACOLOGY (2011)
Anti-Aβ Drug Screening Platform Using Human iPS Cell-Derived Neurons for the Treatment of Alzheimer's Disease
Naoki Yahata et al.
PLOS ONE (2011)
Serotonin signaling is associated with lower amyloid-β levels and plaques in transgenic mice and humans
John R. Cirrito et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
The NCGC Pharmaceutical Collection: A Comprehensive Resource of Clinically Approved Drugs Enabling Repurposing and Chemical Genomics
Ruili Huang et al.
SCIENCE TRANSLATIONAL MEDICINE (2011)
Computational Repositioning of the Anticonvulsant Topiramate for Inflammatory Bowel Disease
Joel T. Dudley et al.
SCIENCE TRANSLATIONAL MEDICINE (2011)
Discovery and Preclinical Validation of Drug Indications Using Compendia of Public Gene Expression Data
Marina Sirota et al.
SCIENCE TRANSLATIONAL MEDICINE (2011)
Open Innovation for Phenotypic Drug Discovery: The PD2 Assay Panel
Jonathan A. Lee et al.
JOURNAL OF BIOMOLECULAR SCREENING (2011)
Effect of a centrally active angiotensin-converting enzyme inhibitor, perindopril, on cognitive performance in a mouse model of Alzheimer's disease
Koji Yamada et al.
BRAIN RESEARCH (2010)
Replication of the LINGO1 gene association with essential tremor in a North American population
Lorraine N. Clark et al.
EUROPEAN JOURNAL OF HUMAN GENETICS (2010)
Human stem cells and drug screening: opportunities and challenges
Allison D. Ebert et al.
NATURE REVIEWS DRUG DISCOVERY (2010)
Alzheimer's disease: strategies for disease modification
Martin Citron
NATURE REVIEWS DRUG DISCOVERY (2010)
VALPROIC ACID ENHANCES MICROGLIAL PHAGOCYTOSIS OF AMYLOID-β1-42
A. M. Smith et al.
NEUROSCIENCE (2010)
Biguanide metformin acts on tau phosphorylation via mTOR/protein phosphatase 2A (PP2A) signaling
Eva Kickstein et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Protective Effects of Intranasal Losartan in the APP/PS1 Transgenic Mouse Model of Alzheimer Disease
Lusine Danielyan et al.
REJUVENATION RESEARCH (2010)
Use of angiotensin receptor blockers and risk of dementia in a predominantly male population: prospective cohort analysis
Nien-Chen Li et al.
BMJ-BRITISH MEDICAL JOURNAL (2010)
Use of angiotensin receptor blockers and risk of dementia in a predominantly male population: prospective cohort analysis
Nien-Chen Li et al.
BMJ-BRITISH MEDICAL JOURNAL (2010)
PDE5 Inhibitors in Non-Urological Conditions
C. Vlachopoulos et al.
CURRENT PHARMACEUTICAL DESIGN (2009)
Drug repositioning using in silico compound profiling
Elodie Dubus et al.
FUTURE MEDICINAL CHEMISTRY (2009)
Phosphodiesterase 5 Inhibition Improves Synaptic Function, Memory, and Amyloid-β Load in an Alzheimer's Disease Mouse Model
Daniela Puzzo et al.
JOURNAL OF NEUROSCIENCE (2009)
Variant in the sequence of the LINGO1 gene confers risk of essential tremor
Hreinn Stefansson et al.
NATURE GENETICS (2009)
Antidiabetic drug metformin (GlucophageR) increases biogenesis of Alzheimer's amyloid peptides via up-regulating BACE1 transcription
Yaomin Chen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Effect of nilvadipine on regional cerebral blood flow in a patient with early Alzheimer disease
Hiroshi Matsuda et al.
CLINICAL NUCLEAR MEDICINE (2008)
Valproic acid inhibits Aβ production, neuritic plaque formation, and behavioral deficits in Alzheimer's disease mouse models
Hong Qing et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2008)
Identification of Small Molecule Inhibitors of β-Amyloid Cytotoxicity through a Cell-Based High-Throughput Screening Platform
K. I. Seyb et al.
JOURNAL OF BIOMOLECULAR SCREENING (2008)
Nilvadipine prevents cognitive decline of patients with mild cognitive impairment
Haruo Hanyu et al.
INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY (2007)
Valsartan lowers brain β-amyloid protein levels and improves spatial learning in a mouse model of Alzheimer disease
Jun Wang et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
Prophylactic treatment with paroxetine ameliorates behavioral deficits and retards the development of amyloid and tau pathologies in 3xTgAD mice
Rhonda L. Nelson et al.
EXPERIMENTAL NEUROLOGY (2007)
Favourable effects of nilvadipine on cognitive function and regional cerebral blood flow on SPECT in hypertensive patients with mild cognitive impairment
Haruo Hanyu et al.
NUCLEAR MEDICINE COMMUNICATIONS (2007)
Innovation - The Connectivity Map: a new tool for biomedical research
Justin Lamb
NATURE REVIEWS CANCER (2007)
The connectivity map: Using gene-expression signatures to connect small molecules, genes, and disease
Justin Lamb et al.
SCIENCE (2006)
Identification of novel small molecule inhibitors of amyloid precursor protein synthesis as a route to lower Alzheimer's disease amyloid-β peptide
Tada Utsuki et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2006)
A clinical drug library screen identifies astemizole as an antimalarial agent
Curtis R. Chong et al.
NATURE CHEMICAL BIOLOGY (2006)
Novel 4-anilinoquinazolines with C-6 carbon-linked side chains:: Synthesis and structure-activity relationship of a series of potent, orally active, EGF receptor tyrosine kinase inhibitors
LFA Hennequin et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2006)
Antihypertensive medication use and incident Alzheimer disease - The Cache County Study
Ara S. Khachaturian et al.
ARCHIVES OF NEUROLOGY (2006)
Treatments for behavioural disorders in neurodegenerative diseases: drug development strategies
JL Cummings et al.
NATURE REVIEWS DRUG DISCOVERY (2006)
Imipramine and citalopram facilitate amyloid precursor protein secretion in vitro
M Pákáski et al.
NEUROCHEMISTRY INTERNATIONAL (2005)
Nilvadipine antagonizes both Aβ vasoactivity in isolated arteries, and the reduced cerebral blood flow in APPsw transgenic mice
D Paris et al.
BRAIN RESEARCH (2004)
A liver X receptor and retinoid X receptor heterodimer mediates apolipoprotein E expression, secretion and cholesterol homeostasis in astrocytes
Y Liang et al.
JOURNAL OF NEUROCHEMISTRY (2004)
Drug repositioning: Identifying and developing new uses for existing drugs
TT Ashburn et al.
NATURE REVIEWS DRUG DISCOVERY (2004)
Galanthamine from snowdrop - the development of a modern drug against Alzheimer's disease from local Caucasian knowledge
M Heinrich et al.
JOURNAL OF ETHNOPHARMACOLOGY (2004)
Efficient reversal of Alzheimer's disease fibril formation and elimination of neurotoxicity by a small molecule
BJ Blanchard et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
The Study on cognition and prognosis in the elderly (SCOPE): principal results of a randomized double-blind intervention trial
H Lithell et al.
JOURNAL OF HYPERTENSION (2003)
Effect of a 5-HT2C serotonin agonist, dexnorfenfluramine, on amyloid precursor protein metabolism in guinea pigs
AA Arjona et al.
BRAIN RESEARCH (2002)
The relationship of hypertension in the elderly to AD, vascular dementia, and cognitive function
HB Posner et al.
NEUROLOGY (2002)
Share Paper
